Biden ad­min­is­tra­tion tar­gets GPOs, whole­salers in re­quest for in­for­ma­tion on gener­ic short­ages

The Fed­er­al Trade Com­mis­sion and De­part­ment of Health and Hu­man Ser­vices are band­ing to­geth­er to glean in­for­ma­tion on how two types of phar­ma mid­dle­men — group pur­chas­ing or­ga­ni­za­tions and drug whole­salers — could be con­tribut­ing to on­go­ing gener­ic drug short­ages.

In a joint re­quest for in­for­ma­tion pub­lished Wednes­day, the two agen­cies ex­pressed skep­ti­cism to­ward the prac­tices of group pur­chas­ing or­ga­ni­za­tions (GPOs) and drug whole­salers, rais­ing flags over how these en­ti­ties could be af­fect­ing drug pric­ing and avail­abil­i­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER